Abiopharma

NU-MED PLUS INC. (NUMD)

Symbol	NUMD
Name	NU-MED PLUS INC.
Sector	UNDEFINED
Region	North America
Industry	-
Address	11777 United States NY 640 Belle Terre Rd. 2 E
Telephone	(631) 403-4337
Fax	—
Email	—
Website	https://www.nu-medplus.com
Incorporation	US
Incorporated On	2011
Employees	—
Fiscal Year	12/31
Public Since	—
Exchanges	OTC
Auditor	Fruci & Associates II, PLLC;
Audit Status	AUDITED
Reporting Status	U.S. Reporting: SEC Reporting
CIK	0001543637
Description	Medical device development and commercialization. Additional info from OTC: Medical device development and commercialization.

2025-11-14 17:42

Nu-Med Plus Inc. (NUMD) Files Form 10-Q

2025-08-11 00:00

(28% Negative) NU-MED PLUS, INC. (NUMD) Reports Net Loss for 2025-06-30

2025-05-22 00:00

(42% Neutral) NU-MED PLUS, INC. (NUMD) Reports Net Loss for 2025-03-31

2025-03-31 20:51

New Form 10-K - Nu-Med Plus, Inc. Filed: 2025-03-31 AccNo: 0001548123-25-000021 Size: 2 MB

2024-11-14 00:00

(28% Negative) NU-MED PLUS, INC. (NUMD) Reports Net Loss for 2024-09-30

2024-10-30 20:07

(99% Neutral) Nu-Med Plus, Inc. (NUMD) Announces New Board Appointment

2024-08-30 16:12

OTCQB symbol attribute type Security_Name was changed. Previous value: -. New value: NU-MED PLUS INC.

2024-08-27 08:15

OTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: NU-MED PLUS INC.

2024-08-21 00:00

(28% Negative) NU-MED PLUS, INC. (NUMD) Reports 34% Loss Increase for 2024-06-30

2024-08-14 18:35

New Form NT 10-Q - Nu-Med Plus, Inc. Filed: 2024-08-14 AccNo: 0001548123-24-000103 Size: 13 KB